Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Epigenetic disruption of cadherin-11 in human cancer metastasis.

Carmona FJ, Villanueva A, Vidal A, Muñoz C, Puertas S, Penin RM, Gomà M, Lujambio A, Piulats JM, Mesía R, Sánchez-Céspedes M, Manós M, Condom E, Eccles SA, Esteller M.

J Pathol. 2012 Oct;228(2):230-40. doi: 10.1002/path.4011. Epub 2012 Jul 26.

2.

Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays.

Kaehler KC, Politz O, Henderson D, Ulbrich HF, Hauschild A, Mund C, Egberts F.

Melanoma Res. 2015 Jun;25(3):225-31. doi: 10.1097/CMR.0000000000000150.

PMID:
25919928
3.

DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.

Venza M, Visalli M, Catalano T, Biondo C, Beninati C, Teti D, Venza I.

Oncol Rep. 2016 Apr;35(4):2451-60. doi: 10.3892/or.2016.4618. Epub 2016 Feb 11.

PMID:
26883095
4.

Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).

Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, Plass C.

J Med Genet. 2003 Jan;40(1):25-33.

5.

Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.

Gao L, van den Hurk K, Moerkerk PTM, Goeman JJ, Beck S, Gruis NA, van den Oord JJ, Winnepenninckx VJ, van Engeland M, van Doorn R.

J Invest Dermatol. 2014 Dec;134(12):2957-2966. doi: 10.1038/jid.2014.270. Epub 2014 Jul 7.

6.

Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.

Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS.

Cancer Res. 2003 Apr 1;63(7):1639-43.

7.

Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.

Misawa K, Kanazawa T, Misawa Y, Imai A, Endo S, Hakamada K, Mineta H.

Cancer Biomark. 2011-2012;10(3-4):135-44. doi: 10.3233/CBM-2012-0242.

PMID:
22674299
8.

CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.

Opavsky R, Wang SH, Trikha P, Raval A, Huang Y, Wu YZ, Rodriguez B, Keller B, Liyanarachchi S, Wei G, Davuluri RV, Weinstein M, Felsher D, Ostrowski M, Leone G, Plass C.

PLoS Genet. 2007 Sep;3(9):1757-69. Epub 2007 Aug 16.

9.
10.

Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.

Metge BJ, Liu S, Riker AI, Fodstad O, Samant RS, Shevde LA.

Oncology. 2010;78(1):75-86. doi: 10.1159/000292363. Epub 2010 Mar 6.

PMID:
20215788
11.

RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.

Helmbold P, Richter AM, Walesch S, Skorokhod A, Marsch WCh, Enk A, Dammann RH.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):687-94. doi: 10.1038/jid.2011.380. Epub 2011 Nov 24.

12.

To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.

Shiwarski DJ, Shao C, Bill A, Kim J, Xiao D, Bertrand CA, Seethala RS, Sano D, Myers JN, Ha P, Grandis J, Gaither LA, Puthenveedu MA, Duvvuri U.

Clin Cancer Res. 2014 Sep 1;20(17):4673-88. doi: 10.1158/1078-0432.CCR-14-0363. Epub 2014 Jun 11.

13.

A microRNA DNA methylation signature for human cancer metastasis.

Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61. doi: 10.1073/pnas.0803055105. Epub 2008 Sep 3.

14.

Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.

Gao L, Smit MA, van den Oord JJ, Goeman JJ, Verdegaal EM, van der Burg SH, Stas M, Beck S, Gruis NA, Tensen CP, Willemze R, Peeper DS, van Doorn R.

Pigment Cell Melanoma Res. 2013 Jul;26(4):542-54. doi: 10.1111/pcmr.12096. Epub 2013 Apr 17.

PMID:
23590314
15.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

16.

Silencing of the thrombomodulin gene in human malignant melanoma.

Furuta J, Kaneda A, Umebayashi Y, Otsuka F, Sugimura T, Ushijima T.

Melanoma Res. 2005 Feb;15(1):15-20.

PMID:
15714116
17.

Patterns of gene promoter methylation in squamous cell cancer of the head and neck.

Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT.

Oncogene. 2002 Jun 20;21(27):4231-6.

18.
19.

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.

Mazar J, Khaitan D, DeBlasio D, Zhong C, Govindarajan SS, Kopanathi S, Zhang S, Ray A, Perera RJ.

PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922. Epub 2011 Sep 19.

20.

Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.

Liu S, Ren S, Howell P, Fodstad O, Riker AI.

Pigment Cell Melanoma Res. 2008 Oct;21(5):545-58. doi: 10.1111/j.1755-148X.2008.00484.x. Epub 2007 Jun 28.

PMID:
18627528

Supplemental Content

Support Center